Sneha Vishwanath

Madingley Road, Cambridge CB3 OES
Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

A phase I, needle free, dose escalation clinical trial of pEVAC-PS, a candidate pan-Sarbecovirus Vaccine.

A phase I, needle free, dose escalation clinical trial of pEVAC-PS, a candidate pan-Sarbecovirus Vaccine.

Journal: The Journal of infection

Published: September 09, 2025

Editorial: Strategies for mitigating zoonotic influenza outbreaks: a comprehensive preparedness approach.

Editorial: Strategies for mitigating zoonotic influenza outbreaks: a comprehensive preparedness approach.

Journal: Frontiers in public health

Published: August 13, 2025

A computational method to design broad-spectrum T cell-inducing vaccines applied to Betacoronaviruses.

A computational method to design broad-spectrum T cell-inducing vaccines applied to Betacoronaviruses.

Journal: Cell reports methods

Published: August 11, 2025

Computationally designed haemagglutinin with nanocage plug-and-display elicits pan-H5 influenza vaccine responses.

Computationally designed haemagglutinin with nanocage plug-and-display elicits pan-H5 influenza vaccine responses.

Journal: Emerging microbes & infections

Published: June 06, 2025

Enhanced variant neutralization through glycan masking of SARS-CoV-2 XBB1.5 RBD.

Enhanced variant neutralization through glycan masking of SARS-CoV-2 XBB1.5 RBD.

Journal: Emerging microbes & infections

Published: May 06, 2025

Computationally designed Spike antigens induce neutralising responses against the breadth of SARS-COV-2 variants.

Computationally designed Spike antigens induce neutralising responses against the breadth of SARS-COV-2 variants.

Journal: NPJ vaccines

Published: July 29, 2023

Immune imprinting and next-generation coronavirus vaccines.

Immune imprinting and next-generation coronavirus vaccines.

Journal: Nature microbiology

Published: March 01, 2023

Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variants.

Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variants.

Journal: Frontiers in immunology

Published: December 07, 2022

Influenza A (N1-N9) and Influenza B (B/Victoria and B/Yamagata) Neuraminidase Pseudotypes as Tools for Pandemic Preparedness and Improved Influenza Vaccine Design.

Influenza A (N1-N9) and Influenza B (B/Victoria and B/Yamagata) Neuraminidase Pseudotypes as Tools for Pandemic Preparedness and Improved Influenza Vaccine Design.

Journal: Vaccines

Published: August 10, 2022

Structures of distantly related interacting protein homologs are less divergent than non-interacting homologs.

Structures of distantly related interacting protein homologs are less divergent than non-interacting homologs.

Journal: FEBS open bio

Published: April 06, 2022

A computationally designed antigen eliciting broad humoral responses against SARS-CoV-2 and related sarbecoviruses.

A computationally designed antigen eliciting broad humoral responses against SARS-CoV-2 and related sarbecoviruses.

Journal: Nature biomedical engineering

Published: November 05, 2021

Pseudotyped Bat Coronavirus RaTG13 is efficiently neutralised by convalescent sera from SARS-CoV-2 infected patients.

Pseudotyped Bat Coronavirus RaTG13 is efficiently neutralised by convalescent sera from SARS-CoV-2 infected patients.

Journal: Communications biology

Published: August 31, 2021

Showing 1-12 of 19

Last Updated: 09/26/2026